Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations

v2.4.0.8
Discontinued Operations
9 Months Ended
Sep. 30, 2013
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations [Text Block]
DISCONTINUED OPERATIONS
On December 29, 2011, we entered into an agreement to sell certain assets of our Pharmakon business unit to Informed in exchange for potential future royalty payments and a 1% ownership interest in Informed. The consolidated statement of operations reflects the presentation of Pharmakon as a discontinued operation in all periods presented.
On July 19, 2010, the Board approved closing the TVG business unit. The Company completed the closure of the TVG operations during the quarter ended September 30, 2010, including the completion of all active customer contracts. The financial statements reflect the presentation of TVG as a discontinued operation in all periods presented.
The table below presents the significant components of Pharmakon's and TVG’s results included in Loss from Discontinued Operations in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the three- and nine-month periods ended September 30, 2013 and 2012.
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2013

2012
 
2013
 
2012
Revenue, net
$

 
$

 
$

 
$

Loss from discontinued operations, before income tax
(27
)
 
(188
)
 
(27
)
 
(200
)
Provision for income tax
1

 
1

 
4

 
4

Loss from discontinued operations, net of tax
$
(28
)
 
$
(189
)
 
$
(31
)
 
$
(204
)

The major classes of assets and liabilities included in the Condensed Consolidated Balance Sheets for TVG and Pharmakon as of September 30, 2013 and December 31, 2012 are as follows:
 
September 30,
2013
 
December 31,
2012
Current assets
$
23

 
$
14

Non-current assets
150

 
150

Total assets
$
173

 
$
164

Current liabilities
$
393

 
$
368

Non-current liabilities
768

 
1,006

Total liabilities
$
1,161

 
$
1,374